Search Results - "Eduardo Vilar Gómez"

High‐quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population by Vilar‐Gomez, Eduardo, Nephew, Lauren D., Vuppalanchi, Raj, Gawrieh, Samer, Mladenovic, Andrea, Pike, Francis, Samala, Niharika, Chalasani, Naga

“…Background and Aims The effects of diet quality (DQ), physical activity (PA), and socioeconomic status (SES) on the risk of NAFLD are unclear. We examined the…”
Get full text

Vitamin E Improves Transplant‐Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis by Vilar‐Gomez, Eduardo, Vuppalanchi, Raj, Gawrieh, Samer, Ghabril, Marwan, Saxena, Romil, Cummings, Oscar W., Chalasani, Naga

“…Vitamin E improves liver histology in adults with nonalcoholic steatohepatitis (NASH) but not diabetes, but its impact on long‐term patient outcomes is…”
Get full text

Editorial: food insecurity, diet quality, racial and ethnic disparities in non‐alcoholic fatty liver disease by Vilar‐Gomez, Eduardo

“…LINKED CONTENT This article is linked to Kardashian et al papers. To view these articles, visit https://doi.org/10.1111/apt.17219…”
Get full text

Editorial: Enriching our understanding of MASLD through representation of under‐reported populations by Samala, Niharika, Vilar‐Gomez, Eduardo

“…LINKED CONTENT This article is linked to Enriquez et al paper. To view this article, visit https://doi.org/10.1111/apt.17931…”
Get full text

PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features by Vilar‐Gomez, Eduardo, Pirola, Carlos J., Sookoian, Silvia, Wilson, Laura A., Liang, Tiebing, Chalasani, Naga

“…Background and Aims It is unclear whether rs738409 (p.I148M) missense variant in patatin‐like phospholipase domain‐containing 3 rs738409 promotes fibrosis…”
Get full text

Editorial: first‐degree relatives of Mexican Americans with HCC are at increased risk of significant fibrosis by Guarnizo‐Ortiz, Maria, Vilar‐Gomez, Eduardo

“…LINKED CONTENT This article is linked to Sharpton et al papers. To view these articles, visit https://doi.org/10.1111/apt.17384 and…”
Get full text

Long‐term metformin use may improve clinical outcomes in diabetic patients with non‐alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis by Vilar‐Gomez, Eduardo, Vuppalanchi, Raj, Desai, Archita, Gawrieh, Samer, Ghabril, Marwan, Saxena, Romil, Cummings, Oscar W., Chalasani, Naga

“…Summary Background Metformin may protect against hepatocellular carcinoma and mortality among patients with type 2 diabetes. Aim To investigate whether…”
Get full text

Racial differences in primary sclerosing cholangitis mortality is associated with community socioeconomic status by Are, Vijay S., Vilar‐ Gomez, Eduardo, Gromski, Mark A., Akisik, Fatih, Lammert, Craig, Ghabril, Marwan, Chalasani, Naga, Vuppalanchi, Raj, Nephew, Lauren D.

“…Background and Aims Natural history and outcomes data in PSC are mostly derived from cohorts where Blacks have been underrepresented. It is unknown if there…”
Get full text

Letter: metformin treatment and hepatocellular carcinoma risk in non‐alcoholic fatty liver disease. Authors’ reply by Vilar‐Gomez, Eduardo, Chalasani, Naga

“…LINKED CONTENT This article is linked to Vilar‐Gomez and et al and Dogru et al papers. To view these articles, visit https://doi.org/10.1111/apt.15331 and…”
Get full text

Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply by Vilar‐Gomez, Eduardo, Chalasani, Naga

“…LINKED CONTENT This article is linked to Vilar‐Gomez et al and Huo et al papers. To view these articles, visit https://doi.org/10.1111/apt.15331 and…”
Get full text

Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States by Gawrieh, Samer, Vilar‐Gomez, Eduardo, Woreta, Tinsay A., Lake, Jordan E., Wilson, Laura A., Price, Jennifer C., Naggie, Susanna, Sterling, Richard K., Heath, Sonya, Corey, Kathleen E., Cachay, Edward R., Ajmera, Veeral, Tonascia, James, Sulkowski, Mark S., Chalasani, Naga, Loomba, Rohit

“…Summary Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) has recently been proposed as a replacement term for NAFLD. Aims To assess…”
Get full text

ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver‐Related Cirrhosis by Calzadilla‐Bertot, Luis, Vilar‐Gomez, Eduardo, Wong, Vincent Wai‐Sun, Romero‐Gomez, Manuel, Aller‐de la Fuente, Rocio, Wong, Grace Lai‐Hung, Castellanos, Marlen, Eslam, Mohammed, Desai, Archita P., Jeffrey, Gary P., George, Jacob, Chalasani, Naga, Adams, Leon A.

“…Background and Aims Nonalcoholic fatty liver disease (NAFLD) is an increasingly important cause of liver cirrhosis and subsequent complications. We…”
Get full text

Clinical characteristics and prognosis of hospitalized patients with moderate alcohol‐associated hepatitis by Gaurnizo‐Ortiz, Maria, Nephew, Lauren D., Vilar‐Gomez, Eduardo, Kettler, Carla D., Slaven, James E., Ghabril, Marwan S., Desai, Archita P., Orman, Eric S., Chalasani, Naga, Gawrieh, Samer, Patidar, Kavish R.

“…Background and Aims Little is known about the clinical characteristics and prognosis of hospitalized patients with moderate alcohol‐associated hepatitis (mAH)…”
Get full text

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers by Vilar-Gomez, Eduardo, Chalasani, Naga

“…The correct identification of patients at increased risk of non-alcoholic steatohepatitis (NASH) and advanced fibrosis is a critical step in the assessment of…”
Get full text

Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy‐proven NASH by Vilar‐Gomez, Eduardo, Calzadilla‐Bertot, Luis, Friedman, Scott L., Gra‐Oramas, Bienvenido, Gonzalez‐Fabian, Licet, Lazo‐del Vallin, Sacha, Diago, Moises, Adams, Leon A.

“…Background & Aims The dynamic response of serum fibrosis biomarkers to histological changes within the liver following lifestyle intervention (LI) is unknown…”
Get full text

Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention by Vilar‐Gomez, Eduardo, Yasells‐Garcia, Ali, Martinez‐Perez, Yadina, Calzadilla‐Bertot, Luis, Torres‐Gonzalez, Ana, Gra‐Oramas, Bienvenido, Gonzalez‐Fabian, Licet, Villa‐Jimenez, Oscar, Friedman, Scott L., Diago, Moises, Romero‐Gomez, Manuel

“…Liver biopsy is the gold standard method to assess nonalcoholic steatohepatitis (NASH) resolution after therapeutic interventions. We developed and validated a…”
Get full text

Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol‐associated hepatitis by Hu, Kunpeng, Perez‐Matos, Maria C., Argemi, Josepmaria, Vilar‐Gomez, Eduardo, Shalaurova, Irina, Bullitt, Esther, Landeen, Lee, Sugahara, Go, Deng, Huiyan, Mathur, Karan, Tran, Stephanie, Cai, Huimei, He, Hanchang, Yalcin, Yusuf, Vieira Barbosa, Joana, Ventura‐Cots, Meritxell, Marx, Katherine, Gad, Aniket P., Niezen, Sebastian, Izunza Barba, Sofia, Ang, Lay‐Hong, Popov, Yury V., Fricker, Zachary, Lai, Michelle, Curry, Michael, Afdhal, Nezam, Szabo, Gyongyi, Mukamal, Kenneth J., Sanyal, Arun J., Otvos, James D., Malik, Raza, Saito, Takeshi, Connelly, Margery A., Chalasani, Naga P., Bataller, Ramon, Jiang, Z. Gordon

“…Background and Aims Lipoprotein Z (LP‐Z) is an abnormal free cholesterol (FC)–enriched LDL‐like particle discovered from patients with cholestatic liver…”
Get full text

The natural history of compensated HCV-related cirrhosis: A prospective long-term study by Gomez, Eduardo Vilar, Rodriguez, Yoan Sanchez, Bertot, Luis Calzadilla, Gonzalez, Ana Torres, Perez, Yadina Martinez, Soler, Enrique Arus, Garcia, Ali Yasells, Blanco, Luis Perez

“…Background & Aims The natural history of HCV-related compensated cirrhosis has been poorly investigated in Latin-American countries. Our study evaluated…”
Get full text

Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden by Dakhoul, Lara, Gawrieh, Samer, Jones, Keaton R., Ghabril, Marwan, McShane, Chelsey, Orman, Eric, Vilar‐Gomez, Eduardo, Chalasani, Naga, Nephew, Lauren

“…Black patients have higher mortality and are less likely to receive liver transplantation for hepatocellular carcinoma (HCC) than white patients. Reasons for…”
Get full text

Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial by Gawrieh, Samer, Wilson, Laura A., Yates, Katherine P., Cummings, Oscar W., Vilar‐Gomez, Eduardo, Ajmera, Veeral, Kowdley, Kris V., Rosenberg, William M., Tonascia, James, Chalasani, Naga

“…Enhanced liver fibrosis score (ELF) and one of its components, amino‐terminal propeptide of type III procollagen (PIIINP) are promising noninvasive biomarkers…”
Get full text